retatrutide fda approval status 2025 is everywhere right now and I get asked about it almost daily. Looking at the evidence: Early phase 3 data released by Eli Lilly showed ~28–29% average weight loss at the Retatrutide FDA Approval 2025–2026: Phase

The process usually begins with a short health questionnaire where you provide details about your weight goals, medical history, and current lifestyle

Shiraishi D, Fujiwara Y, Komohara Y, Mizuta H, Takeya M

Additionally, GLP-1 reduces the release of glucagon, another hormone produced by the pancreas, which typically signals the liver to release stored glucose

In its boldest, most high-profile maneuver, Hims capitalized on a temporary regulatory loophole: an FDA-designated shortage of semaglutide, the active ingredient in blockbuster weight loss drugs like Ozempic and Wegovy

Improvements in cardiometabolic markers : Participants demonstrated reductions in waist circumference, blood pressure, fasting glucose, and triglyceride levels

At higher doses, it may be harder to tolerate, but we wont fully understand its long-term safety risks until we have more data